Susan Morse

The World Health Organization will hold an International Health Regulations Emergency Committee meeting on February 1 to determine whether the outbreak and spread of the Zika virus across constitutes a public health emergency of international concern.

Hospitals in Medicaid expansion states fare better financially than those in states that have not adopted the Affordable Care Act initiative, according to an attorney who formerly directed the Medicaid program for the Centers for Medicare and Medicaid Services.

With the final January 31 deadline for open enrollment looming, close to 9 million consumers have signed up for healthcare coverage through the marketplace, according to the Centers for Medicare and Medicaid Services.

Health insurer Centene on Tuesday said the loss of six hard drives with health info in 950,000 beneficiaries was a result of an employee error.

Hospital groups and other stakeholders have spoken out against a proposal that would cut 10 percent in payments from the Medicare Part B drug pricing program. It's now up to Congress to decide whether to implement the change recommended this month by the Medicare Payment Advisory Commission.

Racial and ethnic minority populations are more likely than their white counterparts to be readmitted within 30 days of discharge for certain chronic conditions.

Donald Trump is calling for a change in the way Medicare deals with big pharma prices, a revision long targeted by Democrats.

Deficiencies found in an audit of Cigna-HealthSpring operations has prompted the Centers for Medicare and Medicaid Services to temporarily bar Cigna from enrolling new customers to its Medicare Advantage and stand-alone prescription drug plans, and from marketing efforts, according to CMS.

The Centers for Medicare and Medicaid Services on Friday said a demonstration of new incentives to align dual-eligible spending shows a 6 percent savings, or $21.6 million, in Medicare spending.

The Centers for Medicare and Medicaid Services on Thursday finalized a rule on the rebate and reimbursement of prescription drugs, a move aimed at bringing down consumer costs and which is expected to save federal and state governments an estimated $2.7 billion over five years.